SAN FRANCISCO — The first-time application of a triple-drug, site-specific antithrombotic therapy on a stent platform was safe and effective for managing thrombotic and bleeding risk after PCI ...

Anticoagulation may be option Further complicating matters is the recent observation that 7% to 40% of patients have leaflet thickening or reduced leaflet motion observed on CT within 3 months ...

Findings from the GEMINI-ACS-1 trial that evaluated the safety of low-dose rivaroxaban vs. aspirin daily in addition to a P2Y12 inhibitor (clopidogrel or ticagrelor) for ACS patients were presented.

Because of the shortcomings of the existing evidence regarding the combination of oral anticoagulation and DAPT, Pascal Vranckx, MD, PhD, of Hartcentrum Hasselt (Hasselt, Belgium), said “the efficacy ...

Patients were grouped according to postoperative antithrombotic therapy; 73% of patients received single-antiplatelet therapy with ASA and 27% received DAPT.

Registry data from EHRA EUROPACE-CARDISTIM 2017 raise concerns that device complications and the need for antithrombotic therapy may limit any potential benefit for left atrial appendage closure.

SAN FRANCISCO -- For ticagrelor-based antithrombotic regimens after drug-eluting stent implantation for acute coronary syndrome (ACS), stopping aspirin within the first month appeared to be safer ...

The purpose of the submission was to demonstrate the safety and effectiveness of DAPT as a post-procedural antithrombotic regimen in NVAF patients who might be looking for an alternative to OAC.

Year in Review Published: 03 January 2018 Antithrombotic therapy in 2017 Advances in atherosclerosis, atrial fibrillation, and valvular disease Deepak L. Bhatt Nature Reviews Cardiology 15, 71 ...